In its five years of existence, the Czech national registry of multiple sclerosis patients, ReMuS, has become an invaluable source of data for both clinical practice and research. This article provides an overview of how the registry has developed since its inception in 2013 and the significance of the data collected for improving the care of multiple sclerosis patients. ReMuS, established by the Endowment Fund IMPULS in collaboration with a professional society, now includes data on more than 13,000 patients in all stages of the disease and regularly provides key information on demographics, disease progression, treatment efficacy, and safety, which help physicians in deciding the most appropriate therapy. The results obtained from the registry reveal not only trends in the use of medicinal products but also the development of diagnostic procedures and the availability of treatment in the Czech Republic.
prof. Dana Horáková, MD, Ph.D.
General University Hospital in Prague
You can read the full article in Czech on the journal's website Neurology for practice.
